|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
2431864 |
| 003 |
ICU |
| 005 |
20060630124200.0 |
| 008 |
960326s1996 nyu b 101 0 eng c |
| 010 |
|
|
|a 96004871
|
| 020 |
|
|
|a 0306452839
|
| 035 |
|
|
|a (ICU)BID21724534
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OrLoB-B
|d OCoLC
|
| 041 |
0 |
|
|a eng
|
| 050 |
0 |
0 |
|a QR189
|b .V28 1996
|
| 060 |
|
0 |
|a QW 805 V11647 1996
|
| 082 |
0 |
0 |
|a 615/.372
|2 20
|
| 245 |
0 |
0 |
|a Vaccines :
|b new generation immunological adjuvants /
|c edited by Gregory Gregoriadis and Brenda McCormack and Anthony C. Allison.
|
| 260 |
|
|
|a New York :
|b Plenum Press,
|c c1996.
|
| 263 |
|
|
|a 9602
|
| 300 |
|
|
|a viii, 192 p.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a NATO ASI series.
|n Series A,
|p Life sciences
|v v. 282
|
| 500 |
|
|
|a "Proceedings of a NATO Advanced Study Institute on Vaccines: New Generation Immunological Adjuvants, held June 24-July 5, 1994, in Cape Sounion, Greece"--T.p. verso.
|
| 500 |
|
|
|a "Published in cooperation with NATO Scientific Affairs Division."
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Adjuvants for new and improved vaccines /
|r A. C. Allison --
|t Liposome mediated immunopotentiation and immunomodulation /
|r N. van Rooijen --
|t Quil A, anti-carbohydrate antibody specificity and biological function /
|r H. Snippe, E. Alonso de Velasco, A. F. M. Verheul and J. T. Poolman --
|t Vaccine adjuvants based on gamma inulin /
|r P. D. Cooper --
|t Interleukin-2 as a co-adjuvant for liposomal tetanus toxoid /
|r M. Gursel and G. Gregoriadis --
|t Design of vaccines for the induction of antibody responses in Th-cell deficient individuals /
|r B. Golding, J. Inman and H. Golding --
|t Strategies for the stimulation of Th cell subsets /
|r H. Golding, M. B. Zaitseva, C. Lapham and B. Golding --
|t Feline immunodeficiency virus as a vaccine model /
|r M. J. Hosie and O. Jarrett --
|t Rational design of vaccine molecules to prevent pertussis /
|r M. T. De Magistris, A. Di Tommaso, M. Pizza and R. Rappuoli --
|t Multicomponent viral vaccines and their use as immunogen delivery systems /
|r P. Roy --
|t Vaccines again HPV of the uterine cervix: Problems in clinical applicability /
|r P. Hirnle and W. Erz --
|t Local chemotherapy of lymph node matastases: Optimization of targeting accuracy /
|r P. Hirnle and W. Erz --
|t Synthetic peptide vaccines: Success at last /
|r R. H. Meloen, J. I. Casal, K. Dalsgaard and J. P. M. Langeveld --
|t Peptide vaccines: New approaches to immunopotentiation /
|r M. J. Francis --
|t Genetic restriction of responses to peptide antigens /
|r M. J. Francis --
|t DNA-based immunization: Prospects for a hepatitis B vaccine /
|r H. L. Davis and R. G. Whalen --
|t Characterization of immune responses elicited by an experimental facilitated-DNA vaccine for human immunodeficiency virus type-1 (HIV-1) /
|r M. J. Newman, L. Cooney, R. Carrano, J. Boyer, W. V. Williams, B. Wang and D. B. Weiner --
|t Recombinant self-replicating RNA vaccines /
|r P. Liljestrom.
|
| 650 |
|
0 |
|a Vaccines
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2010117638
|
| 650 |
|
0 |
|a Immunological adjuvants
|v Congresses.
|
| 650 |
1 |
2 |
|a Vaccines
|x immunology
|v congresses.
|
| 650 |
2 |
2 |
|a Adjuvants, Immunologic
|x therapeutic use
|v Congresses.
|
| 650 |
2 |
2 |
|a Immunotherapy, Active
|v Congresses.
|
| 650 |
|
7 |
|a Immunological adjuvants.
|2 fast
|0 http://id.worldcat.org/fast/fst00967992
|
| 650 |
|
7 |
|a Vaccines.
|2 fast
|0 http://id.worldcat.org/fast/fst01163573
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
|
|a Gregoriadis, Gregory.
|0 http://id.loc.gov/authorities/names/n79077632
|1 http://viaf.org/viaf/44416002
|
| 700 |
1 |
|
|a McCormack, Brenda.
|0 http://id.loc.gov/authorities/names/n94803400
|1 http://viaf.org/viaf/43541284
|
| 700 |
1 |
|
|a Allison, Anthony C.
|q (Anthony Clifford),
|d 1925-
|0 http://id.loc.gov/authorities/names/n50021036
|1 http://viaf.org/viaf/74001223
|
| 710 |
2 |
|
|a North Atlantic Treaty Organization.
|b Scientific Affairs Division.
|0 http://id.loc.gov/authorities/names/n79142766
|1 http://viaf.org/viaf/141814054
|
| 711 |
2 |
|
|a NATO Advanced Study Institute on Vaccines: New Generation Immunological Adjuvants
|d (1994 :
|c Akra Sounion, Greece)
|0 http://id.loc.gov/authorities/names/n96800203
|
| 035 |
|
|
|a (OCoLC)34115315
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 3eaaca32-ab0c-5e6e-82c1-71b52a8e037f
|s 828c7576-bb86-56d0-b541-9582e018e873
|
| 928 |
|
|
|t Library of Congress classification
|a QR189.V280 1996
|l ASR
|c ASR-SciASR
|i 3100003
|
| 927 |
|
|
|t Library of Congress classification
|a QR189.V280 1996
|l ASR
|c ASR-SciASR
|e CRERAR
|b 43165300
|i 4593045
|
